Literature DB >> 32687149

Implications of Test Characteristics and Population Seroprevalence on "Immune Passport" Strategies.

Daniel B Larremore1, Kate M Bubar2, Yonatan H Grad3.   

Abstract

Various forms of "immune passports" or "antibody certificates" are being considered in conversations around reopening economies after periods of social distancing. A critique of such programs focuses on the uncertainty around whether seropositivity means immunity from repeat infection. However, an additional important consideration is that the low positive predictive value of serological tests in the setting of low population seroprevalence and imperfect test specificity will lead to many false-positive passport holders. Here, we pose a simple question: how many false-positive passports could be issued while maintaining herd immunity in the workforce? Answering this question leads to a simple mathematical formula for the minimum requirements of serological tests for a passport program, which depend on the population prevalence and the value of the basic reproductive number, R0. Our work replaces speculation in the press with rigorous analysis, and will need to be considered in policy decisions that are based on individual and population serology results.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; immune passports; positive predictive value; seroprevalence

Mesh:

Substances:

Year:  2021        PMID: 32687149      PMCID: PMC7454323          DOI: 10.1093/cid/ciaa1019

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys.

Authors:  Daniel B Larremore; Bailey K Fosdick; Kate M Bubar; Sam Zhang; Stephen M Kissler; C Jessica E Metcalf; Caroline O Buckee; Yonatan H Grad
Journal:  Elife       Date:  2021-03-05       Impact factor: 8.140

2.  Seroprevalence of SARS-CoV-2 among high-density communities and hyper-endemicity of COVID-19 in Vietnam.

Authors:  Van Thuan Hoang; Thi Dung Pham; Quoc Tien Nguyen; Duy Cuong Nguyen; Duc Thanh Nguyen; Thanh Binh Nguyen; Thi Khanh Thu Tran; Trong Lan Phan; Phan Le Nguyen Vo; Thi Loi Dao; Florence Fenollar; Philippe Gautret
Journal:  Trop Med Int Health       Date:  2022-03-25       Impact factor: 3.918

3.  Why 'one size fits all' is not enough when designing COVID-19 immunity certificates for domestic use: a UK-wide cross-sectional online survey.

Authors:  Corina Elena Niculaescu; Isabel Sassoon; Irma Cecilia Landa-Avila; Ozlem Colak; Gyuchan Thomas Jun; Panagiotis Balatsoukas
Journal:  BMJ Open       Date:  2022-04-15       Impact factor: 2.692

Review 4.  The COVID-19 pandemic: diverse contexts; different epidemics-how and why?

Authors:  Wim Van Damme; Ritwik Dahake; Alexandre Delamou; Brecht Ingelbeen; Edwin Wouters; Guido Vanham; Remco van de Pas; Jean-Paul Dossou; Por Ir; Seye Abimbola; Stefaan Van der Borght; Devadasan Narayanan; Gerald Bloom; Ian Van Engelgem; Mohamed Ali Ag Ahmed; Joël Arthur Kiendrébéogo; Kristien Verdonck; Vincent De Brouwere; Kéfilath Bello; Helmut Kloos; Peter Aaby; Andreas Kalk; Sameh Al-Awlaqi; N S Prashanth; Jean-Jacques Muyembe-Tamfum; Placide Mbala; Steve Ahuka-Mundeke; Yibeltal Assefa
Journal:  BMJ Glob Health       Date:  2020-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.